Helix TCS, Inc. on March 8, 2018, the company and its wholly-owned subsidiary, Helix Acquisition Sub, Inc. entered into an agreement and plan of merger on March 3, 2018 with Bio-Tech Medical Software, Inc. In connection with the Merger, the company’s Board of Directors increased the number of available positions on the Board to seven and appointed four new directors to the Board. Effective June 1, 2018, Terence J. Ferraro, Daniel J. McMahon, Andrew Schweibold and Patrick Vo became directors of the Company, to hold office until the Company’s next annual meeting of stockholders or until their successors are duly elected and qualified. Messrs. Ferraro and Vo will also continue their positions as Chief Software Architect and President and Chief Executive Officer of BioTrackTHC, respectively.